Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Life Sciences Acquires Labcyte

NEW YORK (GenomeWeb) — Beckman Coulter Life Sciences announced today that it has acquired privately held liquid handling firm Labcyte.

Based in San Jose, California, Labcyte has developed an acoustic droplet ejection technology called Echo that uses sound energy for the contactless transfer of samples and reagents. Specific terms of the acquisition were not disclosed.

"Labcyte's unique product portfolio complements our existing liquid handling and laboratory automation business," Beckman Coulter Life Sciences President Jonathan Pratt said in a statement. "It provides new opportunities to develop and enhance time-saving solutions for customer workflows."

With the acquisition, Labcyte will be integrated into Indianapolis-based Beckman Coulter Life Sciences, which is a subsidiary of Danaher.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.